Lexaria Bioscience Corp. (LXRP) financial statements (2021 and earlier)
Company profile
| Business Address |
100 - 740 MCCURDY ROAD KELOWNA, BC V1X 2P7 |
| State of Incorp. | NV |
| Fiscal Year End | August 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 11/30/2020 TTM | 8/31/2020 | 8/31/2019 | 8/31/2018 | 8/31/2017 | 8/31/2016 | 8/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 569 | 1,313 | 1,349 | 1,737 | 2,533 | 93 | 260 | ||
| Cash and cash equivalents | 525 | 1,294 | 1,285 | 1,727 | 2,533 | 93 | 260 | ||
| Short-term investments | 44 | 19 | 64 | 10 | |||||
| Receivables | 427 | 314 | 273 | 266 | 45 | 131 | 31 | ||
| Inventory, net of allowances, customer advances and progress billings | 126 | 117 | 127 | 87 | 67 | 135 | 168 | ||
| Inventory | 126 | 117 | 127 | 87 | 67 | 135 | 168 | ||
| Prepaid expense | 136 | 182 | 69 | 194 | |||||
| Disposal group, including discontinued operation | 49 | ||||||||
| Other undisclosed current assets | 150 | 151 | 215 | ||||||
| Total current assets: | 1,308 | 1,926 | 1,819 | 2,284 | 2,795 | 510 | 675 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 118 | 127 | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 452 | 483 | 591 | 1 | 2 | 2 | |||
| Intangible assets, net (including goodwill) | 296 | 292 | 265 | 147 | |||||
| Intangible assets, net (excluding goodwill) | 296 | 292 | 265 | 147 | |||||
| Other undisclosed noncurrent assets | 63 | 54 | 37 | ||||||
| Total noncurrent assets: | 867 | 902 | 856 | 148 | 65 | 56 | 37 | ||
| TOTAL ASSETS: | 2,174 | 2,828 | 2,675 | 2,432 | 2,860 | 567 | 712 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 83 | 87 | 136 | 36 | 33 | 90 | 33 | ||
| Other undisclosed accounts payable and accrued liabilities | 83 | 87 | 136 | 36 | 33 | 90 | 33 | ||
| Due to related parties | 87 | 59 | 48 | 8 | 43 | 331 | 22 | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 17 | 13 | |||
| Other undisclosed current liabilities | 72 | 80 | |||||||
| Total current liabilities: | 242 | 226 | 185 | 44 | 92 | 434 | 55 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 80 | 89 | 45 | ||||||
| Long-term debt, excluding current maturities | 45 | ||||||||
| Operating lease, liability | 80 | 89 | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | (49) | (59) | |||||||
| Total noncurrent liabilities: | 111 | 120 | 45 | ||||||
| Total liabilities: | 353 | 346 | 185 | 44 | 92 | 479 | 55 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 1,878 | 2,525 | 2,383 | 2,388 | 3,006 | 266 | 772 | ||
| Common stock | 3 | 90 | 79 | 76 | 68 | 51 | 40 | ||
| Additional paid in capital | 30,373 | 30,237 | 26,172 | 22,096 | 16,108 | 11,515 | 10,818 | ||
| Accumulated other comprehensive loss | (14) | ||||||||
| Accumulated deficit | (28,498) | (27,802) | (23,868) | (19,769) | (13,170) | (11,301) | (10,086) | ||
| Stockholders' equity attributable to noncontrolling interest | (57) | (43) | 108 | (238) | (178) | (116) | |||
| Total stockholders' equity: | 1,821 | 2,482 | 2,491 | 2,388 | 2,768 | 88 | 657 | ||
| TOTAL LIABILITIES AND EQUITY: | 2,174 | 2,828 | 2,675 | 2,432 | 2,860 | 567 | 712 | ||
Income statement (P&L) ($ in thousands)
| 11/30/2020 TTM | 8/31/2020 | 8/31/2019 | 8/31/2018 | 8/31/2017 | 8/31/2016 | 8/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 618 | 385 | 223 | 433 | 64 | 41 | 15 | |
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 64 | 41 | 15 | |
| Cost of revenue (Cost of Goods and Services Sold) | (156) | (99) | (23) | (25) | (30) | (46) | (874) | |
| Other undisclosed gross profit | 844 | |||||||
| Gross profit: | 462 | 285 | 200 | 408 | 34 | (5) | (15) | |
| Operating expenses | (4,335) | (4,370) | (4,358) | (7,017) | (1,963) | (1,272) | (1,968) | |
| Operating loss: | (3,873) | (4,085) | (4,158) | (6,609) | (1,929) | (1,277) | (1,983) | |
| Nonoperating income (expense) (Foreign Currency Transaction loss, before Tax) | (1) | |||||||
| Interest and debt expense | (6) | (2) | (32) | |||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 98 | 98 | 314 | |||||
| Loss from continuing operations before income taxes: | (3,775) | (3,987) | (4,158) | (6,296) | (1,935) | (1,279) | (2,015) | |
| Income tax expense | (2) | |||||||
| Other undisclosed loss from continuing operations | (2) | |||||||
| Loss from continuing operations: | (3,778) | (3,989) | (4,158) | (6,296) | (1,935) | (1,279) | (2,015) | |
| Income from discontinued operations | 3 | 49 | ||||||
| Net loss: | (3,775) | (3,989) | (4,158) | (6,296) | (1,935) | (1,279) | (1,966) | |
| Net income attributable to noncontrolling interest | 133 | 151 | 59 | 10 | 60 | 62 | 164 | |
| Other undisclosed net loss attributable to parent | (152) | (246) | (59) | (324) | (181) | |||
| Net loss attributable to parent: | (3,794) | (4,085) | (4,158) | (6,609) | (1,875) | (1,217) | (1,983) | |
| Other undisclosed net income available to common stockholders, basic | 71 | 151 | 59 | 10 | 6 | 2 | 213 | |
| Net loss available to common stockholders, diluted: | (3,723) | (3,934) | (4,099) | (6,599) | (1,869) | (1,215) | (1,771) | |
Comprehensive Income ($ in thousands)
| 11/30/2020 TTM | 8/31/2020 | 8/31/2019 | 8/31/2018 | 8/31/2017 | 8/31/2016 | 8/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (3,775) | (3,989) | (4,158) | (6,296) | (1,935) | (1,279) | (1,966) | |
| Other comprehensive income (loss) | 14 | (14) | ||||||
| Comprehensive loss: | (3,775) | (3,989) | (4,144) | (6,310) | (1,935) | (1,279) | (1,966) | |
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (108) | (59) | 10 | 60 | 62 | 164 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (324) | 32 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (3,883) | (3,989) | (4,203) | (6,623) | (1,875) | (1,217) | (1,771) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.